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ABSTRACT 
Recent studies in India indicate raising trends of cardiovascular disorders like hyper tension, angina pectoris, myocardial infarction, congestive 
heart failure and cardiac arrhythmia. Even in rural areas continuous monitoring of the cardio vascular disorders situation is required by 
repeated cross sectional studies in both urban, rural to plan control measures. Aim of the study to make a survey on cardio vascular disorders in 
local hospitals of aroghya and spandana hosipital in khammam. A cross sectional study was carried out in khammam region in the rural field 
practice area of Mother Teresa Pharmacy College in Sathupally, India. All adults and olders of both genders were included and screened for 
cardio vascular disorders by hosipital survey. Conclusion: It was observed that cardiovascular disorders can be treated within time and proper 
medication. Awareness should be created among the population regarding prevention of cardiovascular disorders. Even though proper 
medication are there, in some cases like heart attack and congestive heart failure the death rate is very high. This is because the patient is not 
able to reach the hospitals in time, not changing their life style modifications, continuing their habits like smoking and alcohol consumption and 
lack of frequent medical checkups. Hence the sincere advise to all the patients those are in the risk of cardiovascular disorders must have to keep 
the corresponding medicines like nitroglycerine tablets (Isosorbide dinitrate)  with them of their pocket every time, avoiding of their habits of 
smoking and alcohol consumption, intake of low calorie diet and maintain their regular medical checkups.        
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INTRODUCTION 
The term Cardiovascular Disease (CVD) refers to any 
disorder of the heart and blood vessels which includes 
Hypertension, Coronary Artery Disease (CAD), Cardiac 
Arrhythmia, Cerebrovascular Disease, Valvulars Heart 
Disease, Cardiomyopathy, peripheral vascular disease, 
congenital cardiac abnormalities, Angina Pectoris, 
Congestive Heart Failure (CHF) and Myocardial Infarction. 
Each disorder has been characterized epidemiologically 
incidence and prevalence rates vary widely by country and 
culture. Because Hypertension, Congestive Heart Failure, 
Cardiac Arrhythmia, Angina Pectoris, Myocardial Infarction 
account for the majority of cardiovascular morbidity and 
mortality in developed countries, those topics are the focus 
of this chapter. The modifiable risk factors include tobacco 
use, high blood pressure, physical inactivity, high blood 
cholesterol, obesity, heavy alcohol consumption, and poor 
nutrition. Non-modifiable risk factors are age and family 
history. For each of the disease categories, the epidemiology, 
etiology, risk indicators and primary prevention, diagnostic 
assessment and treatment and prognosis are discussed. 
Above scenario the medical survey on Cardiovascular 
Diseases like Hypertension, Angina pectoris, Myocardial 
infarction, Congestive Heart Failure Cardiac Arrhythmia. 
1. Hypertension: 
Hypertension is defined as the abnormally raised arterial 
blood pressure. The systolic pressure may increases up to 
150 mm/hg and diastolic pressure increases to 100 mm/hg. 
This is the common disease to affect the most of the peoples. 
Hypertension was caused due to physical inactivity, family 
history and diabetes. It was treated by using drugs like beta 
blockers (Atenolol), calcium channel blockers (Nifedipine) 
and ACE inhibitors (Captopril). And it was prevented by life 
style modification and maintains proper medication.  
2. Angina Pectoris: 
Angina pectoris is defined as the chest pain or pressure 
.usually due to the insufficient flow of oxygenated blood to 
the heart muscle. This is caused due to the anemia, alcohol 
consumption, arrhythmia and hypertension. It was treated 
by using drugs like nitrates, beta blockers, calcium channel 
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blocker, potassium channel Opener and it is modified by life 
style changes and maintain proper medication. 
3. Myocardial Infarction: 
Myocardial infarction is also known as heart attack. When 
decreases or stop the blood flow to the part of the heart or 
damage to the heart muscle, myocardial infarction is caused 
due to the hypertension, anginapectoris and heavy alcohol 
consumption. It was treated by using drugs like statins, beta 
blockers, ACE inhibitors, Aldosterone antagonists. And it is 
modified by life style changes and maintains proper 
medications. 
4. Cardiac Arrhythmia: 
Cardiac arrhythmia is defined as abnormal rhythm of heart 
beat. The heart beat may be increase or decrease. Cardiac 
arrhythmia was caused due to heart failure, cardiomyopathy, 
myocardial infarction and alcohol consumption. It was 
treated by given drugs like calcium channel blockers 
(Diltiazem), amidarone. It is modified by life style changes 
and maintains proper medications. 
5. Congestive Heart Failure: 
Congestive heart failure is also known as heart failure. It is 
referred to as when the heart is unable to pump sufficiently 
to maintain blood flow to the body. It causes due to Angina 
Pectoris, Myocardial Infarction, Arrhythmia Hypertension, 
and Cardiomyopathy. It is treated by using drugs like cardiac 
glycosides sympathomimetics, ACE inhibitors, Diuretics, beta 
adrenergic blockers. Congestive Heart Failure was prevented 
by avoid alcohol; avoid smoking, life style modifications and 
proper medication. 
MATERIALS AND METHODS 
Permission from hospital to investigate the 
Cardiovascular Disorder patients  
To carry out the study we got permission from the college 
principal, the no objection with, and requesting letter to the 
M.F Gopinadh. M.D, D.M, from Spandana hospital and P. 
Subbarao M.D, D.M from Arogya hospital were submit to 
carry out the study. 
Type of study 
Cross sectional community study in Khammam region. 
Study design 
A cross-sectional population-based study. 
Study area 
The study was conducted in the rural area of Khammam, 
Khammam dist, TS, India. The Urban field practice area is 
located in the city of Khammam, totaling a population of 
553,060 (estimated). 
Sampling 
Two Hospitals in the urban field practice area were selected. 
Two hospitals were selected due to their proximity to the 
urban health center to facilitate treatment and follow up of 
the detected cases. In these cities, all eligible adults of both 
genders were screened for cardiovascular disorders by 
hospital survey. 
Interview and data collection 
On visiting the hospitals; all Cardiovascular Disorders 
patients invited to participate in the study and were offered 
to sign a written consent form. All those who agreed were 
included in the study. Data were collected from the study 
participants by face to face interview and physical 
examination on a pretested structured instrument. Physical 
examination included anthropometry (height, weight, waist 
circumference, and hip circumference), blood pressure 
measurements in sitting position, and general examination.  
Different Material & Equipments 
 
 
Methods of measuring the parameter: 
Study area 
The study was conducted in the urban field practice area of 
khammam region, Telangana, India. The urban field practice 
area is located about 70 km from the city of Sathupally 
selected a population of 500 members. 
Sampling 
Around khammam region, we have done survey on 500 heart 
patients in these villages, all eligible adults of both gender 
were screened for cardiovascular patients by hospital 
survey. 
Interview and data collection 
Age: By asking the heart patient information. 
Gender: By physical identification of a person. 
Hypertension: By measuring B.P and by observing patients 
medication. 
High cholesterol: By examine patient medication. 
RESULTS 
Causative Factors: According to this study we have 
identified different causative factors for their Angina 
Pectoris, Myocardial Infractions, Congestive Heart Failure 
Hyper Tension and Cardiac Arrhythmia are causative factors 
for cardio vascular diseases. 
Causative Factors for cardio vascular diseases 
Risk factor No of patients 
Cigarette smoking 375 
Diabetes 400 
High cholesterol 320 
High blood pressure 485 
Sedentary life style 456 
Family history of premature heart 
disease 
258 
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Associated risk factors for cardiac diseases: 
Causes    No. Of Patients 
Lack of physical exercise                                                                    250
Alcohol or smoking or both 100 
Improper diet                                                                                           75
Heredity 50 
Improper life cycle                                                                                  25
 
Prevention: 
 Lifestyle changes and eating diet free from saturated fat 
is must to avoid cholesterol formation in the coronary 
blood vessels  
 Avoiding of alcohol consumption and cigarette smoking 
 Excess body weight is the most common cause of angina 
attack hence weight should be always be under control 
Treatment: 
1. Angina Pectoris: 
The most specific medicine to treat angina is nitroglycerin. It 
is a potent vasodilator that decreases myocardial oxygen 
demand by decreasing the heart's workload. Beta blockers 
and calcium channel blockers act to decrease the heart's 
workload and thus its requirement for oxygen. Nitroglycerin 
should not be given if certain inhibitors such as sildenafil, 
tadalafil, or vardenafil have been taken within the previous 
12 hours as the combination of the two could cause a serious 
drop in blood pressure. Treatments for angina are balloon 
angioplasty, in which the balloon is inserted at the end of a 
catheter and inflated to widen the arterial lumen. Stents to 
maintain the arterial widening are often used at the same 
time. Coronary bypass surgery involves bypassing 
constricted arteries with venous grafts. This is much more 
invasive than angioplasty. 
2. Myocardial Infarction: 
Aspirin is continued indefinitely, as well as another 
antiplatelet agent such as clopidogrel or ticagrelor ("dual 
antiplatelet therapy" or DAPT) for up to twelve months. If 
someone has another medical condition that requires 
anticoagulation (e.g. with warfarin) this may need to be 
adjusted based on risk of further cardiac events as well as 
bleeding risk.  
3. Congestive Heart Failure: 
First-line therapy for people with heart failure due to 
reduced systolic function should include  angiotensin 
receptor blockers are the change the enzyme and it also 
converting enzyme (ACE) inhibitors (ACE-I) or angiotension 
receptor blockers (ARBs) if the person develops a long term 
cough as a side effect of the ACE-I. Use of medicines from this 
class is associated with improved survival and quality of life 
in people with heart failure.  
Beta-adrenergic blocking agents (beta blockers) also form 
part of the first line of treatment, adding to the improvement 
in symptoms and mortality provided by ACE-I/ARB. The 
mortality benefits of beta blockers in people with systolic 
dysfunction who also have atrial fibrillation (AF) is more 
limited than in those who do not have AF. If the ejection 
fraction is not diminished (HFpEF), the benefits of beta 
blockers are more modest; a decrease in mortality has been 
observed but reduction in hospital admission for 
uncontrolled symptoms has not been observed.  
 
 
4. Hypertension: 
 Beta-blocker is one of a drug used to reduce 
hypertension. It works by making our heart beat more 
slowly and with less force, thereby reducing blood 
pressure. But they are found to be less effective than 
other treatments. 
 Calcium channel blockers are very helpful because they 
keep calcium from entering the muscle cells of the heart 
and blood vessels. This method widens the arteries and 
reduces the blood pressure. 
 Angiotension-converting enzyme (ACE) inhibitors have 
a dual mode of action. They prevent the formation of 
angiotension-II, the active vasoconstrictor of Renin-
angiotension-aldosterone system (RAAS) and they 
decrease the metabolism of vasodilator bradykinin 
increasing its availability. These drugs are mostly well 
tolerated except for the occasional cases of non-dose 
dependent side effects of cough and angioedema seen 
sporadically in patients. 
5. Cardiac arrhythmia: 
 Beta-blockers for high blood pressure. 
 Street drugs such as cocaine, marijuana and “speed” or 
methamphetamines.  
 Control cholesterol levels 
 Lose excess weight 
 Eat a heart-healthy diet 
 Avoid tobacco smoke 
 Enjoy regular physical activity 
CONCLUSION  
By performing this intensive survey. We selected the 
cardiovascular disorders as a topic of our survey. We 
collected the literature on the cardiovascular disorders and 
did a wide survey from different cardiac centers (hospitals) 
in that we enquire about their medical history, food habits, 
complications of diseases and the medications are using. 
With this medical survey we concluded that the main 
reasons for getting the cardiovascular disorders: Lifestyle, 
Smoking and alcoholism, Lack of frequent medical checkups. 
We observed that even the patients are suffering with these 
cardiovascular disorders. They are not at all changing their 
lifestyle, food habits and no regular medical checkups. These 
things lead to the increases cardiovascular related death 
rate. Hence the sincere advise to all the patients those are in 
the risk of cardiovascular disorders must have to keep the 
corresponding medicines like nitroglycerine tablets 
(Isosorbide dinitrate)  with them of their pocket every time, 
avoiding of their habits of smoking and alcohol consumption, 
intake of low calorie diet and maintain their regular medical 
checkups. 
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